Hormone replacement therapies (HRT) may soon be cheaper and easier to access, thanks to new Government policy.
The commitment was agreed in parliament at the second reading of the Menopause Bill, introduced by Carolyn Harris, Welsh Labour MP for Swansea East.
The cost of HRT, which is prescribed to ease symptoms associated with the menopause, will be cut, and will save users of the drug hundreds of pounds a year, according to the Department of Health and Social Care.
The Government will work with NHS England to look at implementing longer prescribing cycles, in line with NICE guidelines, to reduce the need to pay frequent prescription charges. It has asked NHS England to review the current barriers to implementing these NICE guidelines.
If this change is implemented, women could only have to pay one charge every 12 months, saving up to £205 a year.
HRT is sometimes classed as two medicines, when it contains the hormones oestrogen and progesterone, which means one course of treatment could cost double that of one course of treatment.
As part of the government-led Women’s Health Strategy, it has pledged to look into combining these two hormone treatments into one prescription, which affects approximately 10% of women accessing HRT.
During the reading, Harris said: 'Menopause support in this country is falling short and failing women. GP training in medical schools, support in workplaces, public health messaging and curriculum content in our schools all need addressing.'
This is a good step, but more needs to be done, said Maria Caulfield, minister for women’s health.
'We have heard loud and clear from women across the country and MPs that menopause support is a key issue we as a government need to do more to address.
'As a woman and a nurse, I am acutely aware of how challenging the symptoms of the menopause can be to live with.
'Cutting the cost of HRT – which can be a lifeline to women severely impacted by menopause - is a great stride forward, but there is more to do.'
A Government consultation on women’s health policy received a record-breaking 110,000 responses earlier this year.
The Civil Service is developing a ‘workplace menopause policy’ to ensure that those affected by the menopause can continue to work.
In addition, the Government will set up a menopause taskforce, co-chaired by Caulfield and Harris. It will be tasked with considering how education and training, workplace policies and peer groups can support menopausal women.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.